Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

Marijuana Legalization Is Linked To ‘Significant Reductions’ In Opioid Overdoses, Federally Funded Study Finds

Tom Angel

Marijuana Moment

Tuesday 19 May 2026

States that legalize medical or recreational marijuana see “significant reductions” in opioid overdoses among adults with employer-sponsored health insurance—indicating that a “substitution” effect may be at play—according to a new federally funded study.

While numerous studies have linked state-level legalization to reduced opioid deaths, researchers at the University of Kentucky’s College of Public Health said their data is the first of its kind to identify an association between cannabis access and non-fatal opioid poisonings.

The study, published in the journal Preventive Medicine Reports, analyzed claims data on 107.5 million commercially insured adults aged 18-64 from all 50 states and Washington, D.C. from 2011 to 2021.

Medical marijuana dispensaries and adult-use cannabis legalization was associated with “significant reductions in non-fatal opioid poisonings in the employer-sponsored insured population, particularly among male and younger populations,” the study authors found.

Specifically, access to medical cannabis dispensaries (MCDs) and recreational cannabis laws (RCLs) were associated with a 15.47 percent and 11.92 percent reduction in non-fatal opioid overdoses per 100,000 enrollees per quarter, respectively.

“The reductions tied to medical dispensaries were significant for both men and women, and especially notable among younger adults ages 18–34, who saw a 23.27 percent reduction,” the researchers found.

“These findings suggest that expanded access to cannabis through MCD and RCL is associated with lower [non-fatal opioid overdoses among] adults with employer-sponsored insurance,” the study said. “Greater cannabis access through MCDs and RCL may reduce [overdoses] in heavily impacted populations, indicating possible substitution of cannabis for opioids.”

Though this speaks to an increasing common theme in cannabis research as it relates to opioid use, this is “the first study to our knowledge, to examine and find a negative association of MCD and RCL with [non-fatal opioid overdoses] in adults with employer-sponsored insurance,” the authors said.

“Findings support continuing evidence-based opioid use disorder treatments, while policymakers treat legalization as complementary and prioritize harm reduction and treatment expansion,” it concludes.

The research was funded through a grant from the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS).

The specific data might be novel, but the takeaway is consistent with a growing body of scientific literature on the broader topic.

For example, another research study found that, as opioids continue to drive overdose deaths, making medical cannabis available and affordable seems to help patients reduce their use of the prescription painkillers.

That research came on the heels of a recent study showing that using medical marijuana appears to help people reduce the use of other medications, including opioids, sleeping aids and antidepressants. They also experience far fewer negative side effects after switching to cannabis from prescription drugs, the study involving more than 3,500 patients found.

https://www.marijuanamoment.net/marijuana-legalization-is-linked-to-significant-reductions-in-opioid-overdoses-federally-funded-study-finds/

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!